Complete ingredient direction
Glycine, cranberry extract, uva ursi, astragalus, ginger, dandelion, nettle, cinnamon and grape seed.
Oral capsules OEM/ODM
A nine-component capsule direction combining glycine and cranberry extract with uva ursi, astragalus, ginger, dandelion, nettle, cinnamon and grape seed. The complete relationship is retained for formulation discussion rather than presenting the short name as a two-component formula.

Prepare a project brief for quotation. Formula, packaging and commercial terms are agreed for the individual project.
Glycine, cranberry extract, uva ursi, astragalus, ginger, dandelion, nettle, cinnamon and grape seed. A nine-component capsule direction combining glycine and cranberry extract with uva ursi, astragalus, ginger, dandelion, nettle, cinnamon and grape seed. The complete relationship is retained for formulation discussion rather than presenting the short name as a two-component formula.
Basic oral supplement manufacturing capability is confirmed. It does not establish a fixed formula, strain count, certification, material origin, allergen status or destination-market approval. Reference packaging is not a daily-use recommendation.
A nine-component capsule direction combining glycine and cranberry extract with uva ursi, astragalus, ginger, dandelion, nettle, cinnamon and grape seed. The complete relationship is retained for formulation discussion rather than presenting the short name as a two-component formula.







Product direction overview
A nine-component capsule direction combining glycine and cranberry extract with uva ursi, astragalus, ginger, dandelion, nettle, cinnamon and grape seed. The complete relationship is retained for formulation discussion rather than presenting the short name as a two-component formula. Ingredient direction: Glycine, cranberry extract, uva ursi, astragalus, ginger, dandelion, nettle, cinnamon and grape seed.
Include the complete ingredient direction, individual material specifications, declaration basis, packaging and intended market for Glycine, Cranberry and Botanical Complex Capsules.
Include the complete ingredient direction, individual material specifications, declaration basis, packaging and intended market for Glycine, Cranberry and Botanical Complex Capsules.
OEM/ODM support scope
Bodakang Bio helps buyers structure product discussions before quotation, sample review and order coordination.
Glycine, cranberry extract, uva ursi, astragalus, ginger, dandelion, nettle, cinnamon and grape seed.
Glycine identity and independent amount declaration. Cranberry extract specification and proposed basis.
Capsule fill, botanical market eligibility and objective label review.
Discuss the product-specific specification, analytical requirements, material documents and destination-market label review. No report, certificate or approval is implied before its scope is checked.
Suitable dosage form
A nine-component capsule direction combining glycine and cranberry extract with uva ursi, astragalus, ginger, dandelion, nettle, cinnamon and grape seed. The complete relationship is retained for formulation discussion rather than presenting the short name as a two-component formula.
Private label customization
Final customization depends on confirmed formula, dosage form, package type, quantity and target market requirements.
Packaging options
Packaging can be discussed after product direction, dosage form and quantity range are clearer.
Suitable buyer types
These pages are written for B2B buyers preparing OEM/ODM and private label project discussions.
Project process
The process keeps buyer requirements, formula direction, packaging needs and document discussion organized before production coordination.
01
02
03
04
05
Formula discussion
Bring your specification or describe the product direction you need.
Project quotation
Commercial terms are confirmed for the agreed project scope.
MOQ and quotation: confirmed for the proposed formula, packaging and order quantity.
Samples: availability, scope, fees and timing are agreed for the individual project.
Production lead time: reviewed after the specification, packaging and order requirements are defined.
Buyer FAQ
Prepare the product and commercial brief before sampling and order confirmation.
No. The direction also includes uva ursi, astragalus, ginger, dandelion, nettle, cinnamon and grape seed. These nine components are retained without treating the reference label as a fixed factory formula.
No. It describes an ingredient and dosage-form direction for procurement. No treatment, organ repair or finished-product efficacy is established.
Retain this direction: Glycine, cranberry extract, uva ursi, astragalus, ginger, dandelion, nettle, cinnamon and grape seed. Provide separate material specifications, proposed quantities and per-unit or per-serving declarations. Source-label information is a reference direction, not a confirmed finished factory formula.
Capsule shell, fill characteristics, excipients and moisture protection can be reviewed against the proposed materials and destination-market requirements. No serving recommendation or fixed amount is established.
Discuss bottle material, closure, label artwork, pack count and transport requirements. Original packaging illustration for the product direction. Final formulation, specifications and packaging are agreed by project.
Send the complete ingredient brief, intended market, packaging and proposed order quantity. MOQ, sample availability, fees and timing, quotation and production lead time are agreed for the individual project; no fixed commercial condition is offered here.
Related product directions
Use these pages to compare dosage forms, adjacent product directions and broader private label support options.